Global Amyotrophic Lateral Sclerosis (ALS) Market - Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Apr 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Amyotrophic Lateral Sclerosis (ALS) Market, By Type (Sporadic ALS, Familial (Genetic) ALS), Treatment (Medication, Physical Therapy, Speech Therapy, Others), Route of Administration (Oral, Injections, Others), End-Users (Hospitals, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027.

Amyotrophic Lateral Sclerosis (ALS) Market

Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (ALS) Market

Global Amyotrophic Lateral Sclerosis (ALS) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

The global Amyotrophic Lateral Sclerosis (ALS) market is majorly driven by the high prevalence of Amyotrophic Lateral Sclerosis (ALS) globally and emergence of drugs treating complication associated with Amyotrophic Lateral Sclerosis (ALS) diseases. In addition, increases in strategic alliances such as geographical alliances and granting the designation such as orphan drug designation is some of the impacting factors that drives the market growth. Nevertheless, insufficient trained expertise or technically skilled professionals coupled with high treatment cost significantly hinder the growth of this market.

Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig's disease is a rare and progressive neurological condition belongs to the heterogenous group of motor neurons disorders that affects mainly the motor neurons which controls the voluntary muscles.               

Global Amyotrophic Lateral Sclerosis (ALS) market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Amyotrophic Lateral Sclerosis (ALS) Market Scope and Market Size

Amyotrophic Lateral Sclerosis (ALS) market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel.

  • Type segment for the market is categorized into Sporadic ALS, Familial (Genetic) ALS
  • Based on treatment, the market is segmented into medication, physical therapy, speech therapy and others
  • The route of administration segment for the Amyotrophic Lateral Sclerosis (ALS) market is segmented into oral, injections and others
  • On the basis of end-users, the market is segmented into hospitals, homecare, specialty centres and others
  • On the basis of distribution channel, the market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy

Global Amyotrophic Lateral Sclerosis (ALS) Market Country Level Analysis

Amyotrophic Lateral Sclerosis (ALS) market is analysed and market size information is provided by country, type, treatment, route of administration end-users and distribution channel as referenced above.

The countries covered in the global Amyotrophic Lateral Sclerosis (ALS) market  report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America represents the largest market share throughout the forecasted period due to the favourable reimbursement policies and presence of refined healthcare infrastructure which can results in effective treatment to patient suffering from the Amyotrophic Lateral Sclerosis (ALS). Europe is considered a competitive market owing to the presence of global marketed as well as domestic key players in this region and growing focuses on the research and development. Asia Pacific and South America are expected to leads the market due to surge population and increase in number of riluzole generic manufacturers.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Amyotrophic Lateral Sclerosis (ALS) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Amyotrophic Lateral Sclerosis (ALS) Market Share Analysis

Amyotrophic Lateral Sclerosis (ALS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Amyotrophic Lateral Sclerosis (ALS) market.

The major players covered in the Amyotrophic Lateral Sclerosis (ALS) market are Sanofi, Covis Pharma, Sun Pharmaceuticals Industries Ltd, Mitsubishi Tanabe Pharma Corporation, BrainStorm Cell Limited, ViroMed Co., Ltd, Ionis Pharmaceuticals, Genervon Biopharmaceuticals, LLC, Biogen, Orphazyme A/S, Orion Pharma, Kringle Pharma, Inc., Aquestive Therapeutics, Apotex Inc, Bausch Health, Neuralstem, Inc., Implicit Bioscience, F. Hoffmann-La Roche Ltd, Cytokinetics, Inc., AB Science, and Advanz Pharmaceutical among  others.

Customization Available: Global Amyotrophic Lateral Sclerosis (ALS) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions